NeuroOne Medical Technologies Corp

NMTC

Company Profile

  • Business description

    NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

  • Contact

    7599 Anagram Drive
    Eden PrairieMN55344
    USA

    T: +1 952 426-1383

    https://www.n1mtc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    18

Stocks News & Analysis

stocks

ASX miner weathers the storm with strong commodity prices

Lower volumes due cyclone activity but revenues hold steady.
stocks

Eli Lilly earnings: Mounjaro/Zepbound’s massive volume growth more than counters price pressure

We’ve raised our fair value estimate of Lilly stock.
stocks

OpenAI missed multiple revenue targets - here’s why it likely won’t IPO this year

Plus, whichever AI company IPOs first defines what “good” looks like.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,954.7021.20-0.24%
CAC 408,114.840.000.00%
DAX 4024,292.38337.821.41%
Dow JONES (US)49,652.14790.331.62%
FTSE 10010,323.2755.55-0.54%
HKSE25,776.53335.31-1.28%
NASDAQ24,892.31219.070.89%
Nikkei 22559,513.12228.200.38%
NZX 50 Index13,039.20135.891.05%
S&P 5007,209.0173.061.02%
S&P/ASX 2008,729.8021.20-0.24%
SSE Composite Index4,112.164.650.11%

Market Movers